Seeking Answers and Treatments for Neurologic Diseases
Neurologic diseases are among the most challenging and mysterious conditions facing doctors and their patients today. Temple researchers have made it their life’s mission to unravel the causes of these diseases. Our goal is simple: to develop better tests and more effective treatments for the benefit of our patients with Alzheimer’s disease, Parkinson’s disease, AIDS dementia, and other neurologic disorders.
Research Focus Areas
Temple doctors and researchers participate in a wide range of research programs and protocols aimed at advancing the treatment of neurological conditions. Our work spans the basic science laboratories of the Lewis Katz School of Medicine at Temple University to patient bedside.
Laboratory investigation into the causes and mechanisms of neurological disease takes place in several Temple research centers. Here, scientists work to open the doors to more effective and targeted treatments—from novel pharmaceuticals and biologicals to therapies with genes, stem cells, and medical devices.
Additionally, Temple doctors and scientists participate in clinical trials, testing the effectiveness of new medications and innovative surgical techniques for treating neurological disorders. Through these clinical trials, we are able to provide patients with access to therapies that aren’t yet available at other centers.
Learn more about our basic sciences and translational neurological research centers at the Lewis Katz School of Medicine:
Ongoing Clinical Trials
Clinical trials provide opportunities for patients to participate in the latest therapies available before they are commercially available. We currently has a number of ongoing clinical trials available for patients with neurological conditions such as stroke or epilepsy:
- A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
- Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
- AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke
- Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
- Follow up After Stroke, Screening and Treatment Clinic (Patient Registry)
For more information about clinical trials at the Temple Neurosciences Center, please ask your physician.